These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38382186)

  • 1. Effect of concomitant use of valproic acid during clozapine initiation on clozapine-induced inflammation among Japanese patients with schizophrenia.
    Kikuchi Y; Komatsu H; Otsuka Y; Ito F; Yada Y; Tanifuji H; Tomita H
    Psychiatry Res; 2024 Apr; 334():115810. PubMed ID: 38382186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Slower clozapine titration than the official Japanese protocol led to fewer inflammatory adverse effects: A retrospective chart review of seven hospitals.
    Kikuchi Y; Komatsu H; Otsuka Y; Ito F; Kanahara N; Tanifuji H; Tomita H
    Schizophr Res; 2024 Jun; 268():98-106. PubMed ID: 37331881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clozapine-induced myocarditis during co-administration of valproate: A case report.
    Jahołkowski P; Niewiadomska J; Wciórka J; Kowalski M; Świtaj P
    Psychiatr Pol; 2019 Oct; 53(5):997-1002. PubMed ID: 31955181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid clozapine dose titration and concomitant sodium valproate increase the risk of myocarditis with clozapine: a case-control study.
    Ronaldson KJ; Fitzgerald PB; Taylor AJ; Topliss DJ; Wolfe R; McNeil JJ
    Schizophr Res; 2012 Nov; 141(2-3):173-8. PubMed ID: 23010488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of titration speed, gender, obesity and concomitant medications on the risk and onset time of clozapine-associated fever among Japanese patients with schizophrenia: retrospective review of charts from 21 hospitals.
    Kikuchi Y; Kurosawa M; Sakata M; Takahashi Y; Yamamoto K; Tomita H; Yoshio T; Yasui-Furukori N
    Br J Psychiatry; 2024 Nov; 225(5):492-498. PubMed ID: 39104017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Four cases of myocarditis in US hospitals possibly associated with clozapine poor metabolism and a comparison with prior published cases.
    Koenig M; McCollum B; Spivey JK; Coleman JK; Shelton C; Cotes RO; Goldsmith DR; De Leon J
    Neuropsychopharmacol Hung; 2022 Mar; 24(1):29-41. PubMed ID: 35451590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproate, obesity and other causes of clozapine poor metabolism in the context of rapid titration may explain clozapine-induced myocarditis: A re-analysis of a Turkish case series.
    Ertuğrul A; Anıl Yağcıoğlu AE; Ağaoğlu E; Karakaşlı AA; Ak S; Yazıcı MK; de Leon J
    Rev Psiquiatr Salud Ment (Engl Ed); 2022; 15(4):281-286. PubMed ID: 36513403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clozapine-induced myocarditis may be associated with rapid titration: A case report verified with autopsy.
    Chopra N; de Leon J
    Int J Psychiatry Med; 2016; 51(1):104-15. PubMed ID: 26681239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can Slow Personalized Titration Using C-Reactive Protein Monitoring Decrease the High Rates and Mortality of Clozapine-Associated Myocarditis Seen in Some Countries? A Call for Research.
    de Leon J
    J Clin Psychopharmacol; 2024 May-Jun 01; 44(3):212-219. PubMed ID: 38595145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The incidence and characteristics of clozapine- induced fever in a local psychiatric unit in Hong Kong.
    Pui-yin Chung J; Shiu-yin Chong C; Chung KF; Lai-wah Dunn E; Wai-nang Tang O; Chan WF
    Can J Psychiatry; 2008 Dec; 53(12):857-62. PubMed ID: 19087484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for clozapine-induced myocarditis and cardiomyopathy: A systematic review and meta-analysis.
    Vickers M; Ramineni V; Malacova E; Eriksson L; McMahon K; Moudgil V; Scott J; Siskind D
    Acta Psychiatr Scand; 2022 May; 145(5):442-455. PubMed ID: 35067911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clozapine-related pericarditis during titration phase in a patient with resistant schizophrenia and concomitant valproate treatment: a case report.
    De Berardis D; Campanella D; Serroni N; Rapini G; Olivieri L; Fornaro M; Valchera A; Iasevoli F; Napoletano C; Martinotti G; Giannantonio MD
    J Clin Psychopharmacol; 2014 Oct; 34(5):649-51. PubMed ID: 25006818
    [No Abstract]   [Full Text] [Related]  

  • 13. A 12-month audit of clozapine associated myocarditis in a South Australian Local Health Network: The importance of screening and personalised titration.
    Carswell O; Wilton LR; Nicholls K; Thomas V; Clark SR
    Schizophr Res; 2024 Jun; 268():88-93. PubMed ID: 37722933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid Rechallenge with Clozapine Following Pronounced Myocarditis in a Treatment-Resistant Schizophrenia Patient.
    Ittasakul P; Archer A; Kezman J; Atsariyasing W; Goldman MB
    Clin Schizophr Relat Psychoses; 2016; 10(2):120-2. PubMed ID: 27440213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels.
    de Leon J; Schoretsanitis G; Smith RL; Molden E; Solismaa A; Seppälä N; Kopeček M; Švancer P; Olmos I; Ricciardi C; Iglesias-Garcia C; Iglesias-Alonso A; Spina E; Ruan CJ; Wang CY; Wang G; Tang YL; Lin SK; Lane HY; Kim YS; Kim SH; Rajkumar AP; González-Esquivel DF; Jung-Cook H; Baptista T; Rohde C; Nielsen J; Verdoux H; Quiles C; Sanz EJ; De Las Cuevas C; Cohen D; Schulte PFJ; Ertuğrul A; Anıl Yağcıoğlu AE; Chopra N; McCollum B; Shelton C; Cotes RO; Kaithi AR; Kane JM; Farooq S; Ng CH; Bilbily J; Hiemke C; López-Jaramillo C; McGrane I; Lana F; Eap CB; Arrojo-Romero M; Rădulescu FŞ; Seifritz E; Every-Palmer S; Bousman CA; Bebawi E; Bhattacharya R; Kelly DL; Otsuka Y; Lazary J; Torres R; Yecora A; Motuca M; Chan SKW; Zolezzi M; Ouanes S; De Berardis D; Grover S; Procyshyn RM; Adebayo RA; Kirilochev OO; Soloviev A; Fountoulakis KN; Wilkowska A; Cubała WJ; Ayub M; Silva A; Bonelli RM; Villagrán-Moreno JM; Crespo-Facorro B; Temmingh H; Decloedt E; Pedro MR; Takeuchi H; Tsukahara M; Gründer G; Sagud M; Celofiga A; Ignjatovic Ristic D; Ortiz BB; Elkis H; Pacheco Palha AJ; LLerena A; Fernandez-Egea E; Siskind D; Weizman A; Masmoudi R; Mohd Saffian S; Leung JG; Buckley PF; Marder SR; Citrome L; Freudenreich O; Correll CU; Müller DJ
    Pharmacopsychiatry; 2022 Mar; 55(2):73-86. PubMed ID: 34911124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 25-Year-Old Man with Refractory Schizophrenia and Clozapine-Induced Myocarditis Diagnosed by Non-Invasive Cardiovascular Magnetic Resonance.
    Brazile T; Barakat AF; Bukhari S; Schelbert EB; Soman P
    Am J Case Rep; 2021 May; 22():e930103. PubMed ID: 33990535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When, Why and How to Re-challenge Clozapine in Schizophrenia Following Myocarditis.
    Qubad M; Dupont G; Hahn M; Martin SS; Puntmann V; Nagel E; Reif A; Bittner RA
    CNS Drugs; 2024 Sep; 38(9):671-696. PubMed ID: 38951464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful rechallenge after clozapine-associated myocarditis.
    Holden J; Begum M
    BMJ Case Rep; 2022 May; 15(5):. PubMed ID: 35550318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protocol for Clozapine Rechallenge in a Case of Clozapine-Induced Myocarditis.
    Shivakumar G; Thomas N; Sollychin M; Takács A; Kolamunna S; Melgar P; Connally F; Neil C; Bousman C; Jayaram M; Pantelis C
    Can J Psychiatry; 2020 Jul; 65(7):448-453. PubMed ID: 31818135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocarditis after administration of clozapine.
    Kontoangelos K; Loizos S; Kanakakis J; Smyrnis N; Economou M; Bergiannaki JD; Papadimitriou GN
    Eur Rev Med Pharmacol Sci; 2014 Aug; 18(16):2383-6. PubMed ID: 25219841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.